Navigation Links
Hard To Treat Diseases (HTDS) Equipment Purchase, and General Update on its Cancer and Anti Aging Projects
Date:9/10/2009

BELGRADE, Serbia, Sept. 10 /PRNewswire-FirstCall/ - HTDS www.htdsmedical.com The company is pleased to announce that its operating subsidiary Slavica Bio Chem www.slavicabiochem.com has acquired new equipment for its research work.

    The equipment is accessory mini Protean Tetra System from BioRad.
   http://www.expressionproteomics.com/LifeScience/pdf/Bulletin_3095.pdf

Dr.Ivana Gadjanski HTDS Medical Liaison Correspondent said: "To our followers who are interested in what this apparatus does in summary, Mini Protean Tetra System is a system for 2D electrophoresis which can be used for Western blotting. The new system runs both hand cast gels and Ready Gel Precast Gels interchangeably. The new apparatus will significantly enhance the sample processing procedure. The cell can run one or four gels, and the mini tank is compatible with other Bio-Rad electrode modules for tank blotting, 2D electrophoresis and electroelution".

In other company news, the company has received several unsolicited proposals from other medical companies for its rights in the cancer research and anti aging projects. The company is also considering a merger proposal of its cancer research and anti aging project only, and the positive impact and values this exercise may bring upon the whole organization.

Originally the details were very sketchy and not worth mentioning in a news release or a filing. Over time this began to crystallize and now the company is of the opinion that this is a becoming a significant event, which its shareholders and followers should be made aware of.

The company has scheduled October 7 to October 11 as a date to review, and discuss the split off, sale or merger of its cancer research and anti aging projects and expects to make an announcement on this topic shortly thereafter.

The company will provide further updates on the aforementioned merger / sale of its cancer research and anti aging projects via Pink Sheets filing service with any operational updates in order to keep its followers informed.

More updates on other business activities of Slavica Bio Chem and Mellow Hope the company's China based operations will follow shortly and on a timely basis.

Safe Harbor Statement

Information in this filing may contain statements about future expectations, plans, prospects or performance of Hard to Treat Diseases, Inc. that constitute forward-looking statements for purposes of the safe harbor Provision's under the Private Securities Litigation Reform Act of 1995. The words or phrases "can be," "expects," "may affect," "believed," "estimate," "project," and similar words and phrases are intended to identify such forward-looking statements. HTDS Corporation cautions you that any forward-looking information provided by or on behalf of Hard to Treat Diseases, Inc. is not a guarantee of future performance. None of the information in this filing constitutes or is intended as an offer to sell securities or investment advice of any kind. Hard to Treat Diseases, Inc.'s actual results may differ materially from those anticipated in such forward-looking statements as a result of various important factors, some of which are beyond Hard to Treat Diseases, Inc.'s control. In addition to those discussed in Hard to Treat Diseases, Inc.'s press releases, public filings, and statements by Hard to Treat Diseases, Inc.'s management, including, but not limited to, Hard to Treat Diseases, Inc.'s estimate of the sufficiency of its existing capital resources, Hard to Treat Diseases, Inc.'s ability to raise additional capital to fund future operations, HTDS Corporation's ability to repay its existing indebtedness, the uncertainties involved in estimating market opportunities and, in identifying contracts which match Hard to Treat Diseases, Inc.'s capability to be awarded contracts. All such forward-looking statements are current only as of the date on which such statements were made. Hard to Treat Diseases, Inc. does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events.

CONTACT: For medical and scientific dialogue inquiry only, please contact medicalinfo@htdsmedical.com; For any corporate matters, please contact www.minamargroup.com/helpdesk


'/>"/>
SOURCE Hard to Treat Diseases
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Closing the Addiction Treatment Gap (CATG) Statement on Annual National Survey on Drug Use and Health Data Released by the Substance Abuse and Mental Health Services Administration (SAMHSA)
2. Video: Edie Falco and Cynthia Nixon Appear in New Stand Up To Cancer(TM) PSAs Designed to Educate Cancer Patients About the Importance Of Lowering Ones Risk of Infection During Treatment
3. New Mobile STAR Cranial Center of Excellence Vehicle Brings Cutting-Edge Treatment to Satellite Communities
4. Treating Workers Mental Woes May Boost Productivity
5. Three Million Cases of Major Depressive Disorder Have Comorbid Panic Attack and Are Untreated in the U.S.
6. QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena(TM) (Ospemifene Tablets) in Treatment of Postmenopausal Vaginal Atrophy
7. GENova files patent for new breast cancer treatment
8. New Study a 'Wake Up Call' For the Urgent Need for Sleep Apnea Treatment
9. SEIU Local 721 Calls for Attorney General to Investigate Self-Dealing and $22 Million in Extra Costs at Tarzana Treatment Center
10. Wed., Sept. 16, 11 AM News Conference: Sioux Falls Keystone Treatment Center Is National HQ to Lead 100 Locations Nationwide in Balloon Liftoff Celebrating Recovery Against New Wave of Drug Abuse; Former U.S. Drug Czar/4-Star Gen. Barry McCaffrey, Lieute
11. Hard to Treat Diseases, Inc. (HTDS) and Landstar Inc (LDSR) Retain Auditors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... May 26, 2017 , ... Somnoware, a ... portable sleep monitor with its Somnoware Sleep Device Interface (SDI). Somnoware SDI is ... device operations. With this platform, initializing devices and importing studies are just one-click ...
(Date:5/26/2017)... ... May 26, 2017 , ... On May 24, the Congressional Budget ... the U.S. House on May 4, would result in 23 million Americans losing their ... of the 2010 Patient Protection and Affordable Care Act (ACA). , “It is ...
(Date:5/26/2017)... ... May 26, 2017 , ... Rob Lowe acts as host and helps educate ... is on hiking in American. Viewers can reconnect with America as it explores some ... , Many consumers have looked for an inventive new place for a family vacation, ...
(Date:5/26/2017)... ... 26, 2017 , ... Centennial-based BluSky Restoration Contractors announced that ... Annual Clays for Kids fundraiser, to be held Friday, Sept. 22, at Kiowa ... part of BluSky’s partnership with The Adoption Exchange, BluSky will also share sponsorship ...
(Date:5/24/2017)... ... May 24, 2017 , ... ... Center CEO Mary Ellen, hospital employees, and town officials to celebrate the grand ... facility was developed by Rendina as part of its ongoing relationship with RWJBarnabas ...
Breaking Medicine News(10 mins):
(Date:5/12/2017)... China and Canada joint tech company Laughing Face ... and detergent, and features a powerful disinfection process. The ... that washes and sanitizes women,s panties or babies, cloth diapers in ... ... require an external water inlet. ...
(Date:5/10/2017)... Mass., May 10, 2017 Hologic, Inc. (Nasdaq: ... results for the fiscal second quarter ended April 1, ... of $1.84 increased 666.7% compared to the prior year ... resulted in a significant gain, while non-GAAP diluted EPS ... 3.2%, or 3.8% in constant currency terms.  Excluding the ...
(Date:5/10/2017)... WASHINGTON , May 10, 2017  The ... doctors or employees of sleep therapy clinics to ... a sleep therapy clinic is involved in a ... as interested in hearing from an employee of ... involved in a kickback scheme to provide medical practice ...
Breaking Medicine Technology: